Inhibition of acyl-coa binding protein (acbp) by means of a gabaarγ2-derived peptide

GK is supported by the Ligue contre le Cancer (équipe labellisée); Agence National de la Recherche (ANR) – Projets blancs; AMMICa US23/CNRS UMS3655; Association pour la recherche sur le cancer (ARC); Cancéropôle Ile-de-France; European Research Council Advanced Investigator Grant “ICD-Cancer”, FRM; a donation by Elior; Equipex Onco-Pheno Screen; European Joint Programme on Rare Diseases (EJPRD); European Research Council (ICD-Cancer), European Union Horizon 2020 Projects Oncobiome and Crimson (grant agreement No. 101016923); Fondation Carrefour; Institut National du Cancer (INCa); Institut Universitaire de France; LabEx Immuno-Oncology (ANR-18-IDEX-0001); a Cancer Research ASPIRE Award from the Mark Foundation; the RHU Immunolife; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and SIRIC Cancer Research and Personalized Medicine (CARPEM). This study contributes to the IdEx Université de Paris ANR-18-IDEX-0001. UN-R is supported by Axudas de apoio á etapa de formación posdoutoral da Xunta de Galicia –GAIN. N° Expediente: IN606B-2021/015. ES is supported by the University of Las Palmas de Gran Canaria (ULPGC), financed by the Ministry of Universities (UNI/501/2021), and by the European Union-Next Generation EU Funds. The authors thank the CRC core facilities (especiallyCEF) for the technical and methodological help, assistance and support. Slide preparation was performed by PETRA platform and image acquisition was performed by the CRC “Histology, Imaging and Cytometry Center (CHIC)”.